Skip to main content
Full access
Opinion
Published Online: 21 March 2018

The Developmental Path for a Pediatric Neuropsychiatry Clinical Program

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Roots of Pediatric Neuropsychiatry

Neuropsychiatry as a specialty medical field may be considered a natural offshoot of modern neurology and psychiatry. However, the development of pediatric neuropsychiatry is less well-defined. In the latter part of the 20th century, general psychiatry training programs, which had been heavily geared toward talk therapy or psychoanalysis, gradually embraced the burgeoning revolution in psychopharmacology and became more medically oriented. Along with the positive results of empirical treatment studies and the ascent of categorical diagnostic systems, medical model psychiatry became more scientifically based, paving the way for the subspecialty of “adult” neuropsychiatry.1,2
On the other hand, the medical model and the revolution of psychopharmacology did not permeate most archetypes of child psychiatry. Developmental psychology and practical psychoanalysis dominated the field, even while general psychiatry had become more medically based. As a result, even today, neuropsychiatric conditions in pediatric populations are typically treated by other specialists. Interdisciplinary conditions, such as Tourette’s syndrome and epilepsy, are commonly addressed by child neurologists. Autism spectrum disorders and other intellectual or developmental disabilities are commonly addressed by pediatricians, often developmental pediatricians, or in some cases by practitioners designated as developmental neuropsychiatrists. Currently, no pediatric neuropsychiatry training programs focusing on interdisciplinary conditions, such as epilepsy or traumatic brain injury, exist. Thus, few child and adolescent psychiatrists use a “neuropsychiatric” paradigm for diagnosis and treatment.

Epilepsy as an Entry to Pediatric Neuropsychiatry

Despite the lack of clear characterization of pediatric neuropsychiatry as a subspecialty, a marked clinical need for this type of clinical expertise exists. In one particular condition, epilepsy, the lack of neuropsychiatry services has proven to adversely affect efforts to provide comprehensive care and optimize outcomes.3 Increasingly over the past decade, a greater appreciation for psychiatric comorbidity in epilepsy has been appreciated in adult and in pediatric patients.4 A common lament among neurologists is the shortage of psychiatrists available to provide consultation and comprehensive care.
Anecdotally, it has been noted that in many epilepsy programs, neurologists avoid inquiries about depression or suicide due to fear of being in the uneasy conundrum of requiring prompt consultation that cannot be reliably obtained. Facing a dearth of child psychiatrists, neurologists have become dependent on social workers and neuropsychologists to serve as requisite specialists amid the various components in tertiary care pediatric epilepsy programs.5 A building grassroots effort in clinical and academic neurologic practice has highlighted endeavors to establish acumen in child psychiatry specifically to provide comprehensive care and to improve outcomes.6 The academic literature has continued to expand in the area of neuropsychiatric complications of epilepsy, although treatment efforts have only slowly become more refined, given the absence of a high-quality evidence base.7

Neuropsychiatry in Epilepsy Programs

Given the clear need to provide neuropsychiatric care in pediatrics, we sought to start a pediatric neuropsychiatry clinical program. We started the program at the Kennedy Krieger Institute, which is a tertiary care facility devoted to disorders of the brain and spinal cord in children. Most clinicians are subspecialized neurodevelopmental pediatricians or pediatric neurologists, with a sizeable contingent of child psychiatrists and psychologists, many with notable expertise in caring for children and adolescents with autism spectrum disorder or other intellectual or developmental disabilities. Many patients seeking care at Kennedy Krieger Institute require a complementary neurologic and psychiatric approach to evaluation and treatment, if not physical involvement of multiple disciplines. The institute is physically adjacent to the campus of Johns Hopkins Hospital, which provides convenient clinical referral and academic affiliation and collaboration.
To be interconnected with the institutional culture, we emphasized neuropsychiatric comorbidity of a single condition and defined the program as the Neuropsychiatry in Epilepsy Program. We incorporated administrative support staff to gather demographic information and process referrals. Most referrals initially came directly from epileptologists who identified psychiatric complications that could not be well managed in the outpatient neurology setting. Most patients who were referred were of pediatric age. However, depending upon availability, we also offered evaluations to young adults. We did not offer to provide geriatric evaluations.

Focus of Neuropsychiatric Assessment

Typical evaluations include nursing assessments, medical and neurologic history, targeted neurologic physical examinations, and office-based cognitive testing. Neurologic and mental health evaluations are conducted during the same session. Parents of prospective patients complete clinically oriented questionnaires geared toward general behavioral conditions, though skewed toward impulse control, mood, and executive function. Examples include the Behavioral Assessment System for Children,8 the Behavior Rating Inventory of Executive Function,9 and the Quality of Life Scales for Epilepsy.10 Adolescents complete self-report versions of these measures whenever appropriate.
Evaluations include details consistent with standard child psychiatry assessments. However, additional emphasis is given to the presence of psychiatric symptoms in the context of underlying seizure disorder. Furthermore, an additional complication is that epilepsy pathophysiology may be considered to extend well beyond discrete seizure events; prodromal and postictal periods may extend for hours or even days. Thus, the timing of behavioral symptoms often relates to seizure events at least peripherally. Careful assessment of seizure localization is also important, since psychiatric conditions may be associated with specific seizure types or localization. Temporal lobe foci seem to be preferentially associated with mood symptoms, and attention or learning disorders may be particularly common in patients with generalized seizures.11,12
Rather than exclude psychiatric conditions that seem closely associated with seizure events, we consider diagnoses broadly. We found it very difficult and often impractical to separate psychiatric illness from epilepsy or even to consider either condition as truly episodic. Epilepsy is usually a chronic condition, with flare-ups in the form of seizure events. However, psychiatric illness may take the same form, especially in the form of episodic mood disorder or as psychotic breaks. Because actual seizure events cannot be fully isolated from the pathological processes of the underlying epilepsy, it may be that the associated psychiatric disorder also cannot be separated from the underlying epilepsy. For that reason, we did not consider diagnoses such as adjustment disorders or other conditions that implied that psychiatric disorders would always result from or be secondary to epilepsy.

Neuropsychiatry in Epilepsy Program Evaluations

Over the first year of the program, nearly 100 evaluations were completed. The vast majority of the referrals came from neurologists or epilepsy specialists. Most referrals came from the wider mid-Atlantic geographic region, with some referrals from overseas or from different regions of the United States. The most common psychiatric comorbidities identified were attention deficit hyperactivity disorder and anxiety disorders. Some patients had learning disorders or intellectual or developmental disabilities. Patients with nonepileptic episodes were relatively uncommon. The most common referral questions had to do with hyperactive, impulsive, or aggressive behavior or anxiety and mood symptoms.
Approximately one-third of the patients referred sought ongoing care and continued with treatment that included medical strategies, individual and family therapy, and, in some cases, group therapy. Groups that were specific to epilepsy formed whenever critical numbers of children and adolescents could be recruited. Referrals for full batteries of neuropsychological testing were done when school placement and curriculum refinement were significant concerns. Treatment team members routinely communicated in order to facilitate a cohesive approach to medication trials and to determine epilepsy stability. Case conferences were done for patients of concern, either informally or in the context of weekly meetings.

Pressure for Expansion of the Clinical Focus

Gradually, we realized that the restriction for epilepsy, while sufficient to well surpass productivity targets of involved clinicians, only scratched the surface of the potential conditions addressed by a pediatric neuropsychiatry approach. In the typical course of assessing referred patients within the program, we noted that in some cases the epilepsy was not active. Instead, other conditions were more prominent, namely migraines and complex metabolic conditions.
Over subsequent years, we started accepting referrals for persons with other neurologic conditions that similarly had complicating psychiatric symptoms. Illnesses include a variety of categories, including congenital conditions, brain injury, metabolic disorders, genetic conditions, and immunologic conditions. After accepting these referrals, we found that the number of persons with congenital brain diseases or complex medical conditions increased. As the focus expanded, we also found that anxiety disorders and panic disorder were more prevalent in referred cases.
We also received pressure to expand our age range for evaluations. While we had typically accepted referrals for young adults with epilepsy, there was strong interest in us evaluating young or middle-aged adults with complex conditions. As much as possible, we welcomed these referrals, and eventually noted that nearly one in five referred patients was over 18 years old. The goal for all of these neuropsychiatric evaluations was the same: to address conditions that overlapped medical specialties and involved complex brain and behavior relationships. In doing so, the goal was to formulate treatment recommendations and understanding markedly greater than what could be obtained with a narrower paradigm of treatment. Demographic characteristics of patients referred early and later in the program are presented in Table 1. Details of the conditions present in patients referred in the first year and for the total of the program (up to 3 years) are summarized in Table 2.
TABLE 1. Demographic Characteristics of Referred Patientsa
CharacteristicFirst YearSubsequent Years
Mean age (years)11.614.0
Median age (years)11.013.0
Standard deviation5.85.7
Number of referrals ≥18 years old11/9823/135
a
Ninety-eight referrals occurred in the first year, with 11.2% ≥18 years old. A total of 135 referrals occurred in subsequent years, with 17.0% ≥18 years old.
TABLE 2. Principal Diagnosis of Referred Patients Without Epilepsya
ConditionFirst YearTotal
Migraine44
Concussion33
Disruptive behavior in context of intellectual and developmental disabilities48
Congenital brain disease (stroke, hydrocephalus, cerebral palsy)318
Complex medical illness (mitochondrial, pain, metabolic, sleep disorder)616
Anxiety/panic disorders09
Nonepileptic events15
a
In the first year, 21.4% (N=21/98) of referred patients had conditions other than epilepsy. This proportion increased to 27.5% (N=64/233) when referrals were included from subsequent years.

The Future of Pediatric Neuropsychiatry

Our experience with the Neuropsychiatry in Epilepsy Program has been very persuasive. A tertiary care clinical neuropsychiatry program geared specifically toward epilepsy can be very successful. Additionally, the demand for neuropsychiatric consultation in pediatrics extends beyond epilepsy and also extends beyond typical pediatric ages. Persons of transitional age seemed to be particularly in need of neuropsychiatry services. At this point, our clinical services have become saturated, and we are seeking additional clinicians to enable us to expand services.
Pediatric neuropsychiatrists are rare—only a few are members of the American Neuropsychiatric Association—and no established training curriculum for this subspecialty exists. Yet, given our experience, the field is in very high demand. Perhaps a similar path of development might have occurred in undergraduate education in the past. Not so long ago, colleges would only offer students a single option to major in biology. Students seeking a curriculum in neurosciences would have little recourse but to select biology or psychology as their concentration and then try to find interdisciplinary experts who were rare, or if present were likely to be mavericks within their home science departments.
Today, colleges routinely offer multiple subtypes of biology majors and in many cases the option to major in neuroscience. The availability of different courses of study reflects the new knowledge base and the trend toward an interdisciplinary approach. Clearly the same needs to apply to subspecialty fields of medicine in order to reflect the changing times and improved knowledge base. Pediatric neuropsychiatry is intuitively a subspecialty field that warrants expansion. Our experience of applying neuropsychiatric paradigms to treatment in this population has been rewarded and sustained by overwhelming clinical demand. That alone suggests that pediatric neuropsychiatry has an important and bright future.

Acknowledgments

The author thanks the Care Center and Nursing Staff in the Department of Psychiatry at the Kennedy Krieger Institute.

References

1.
Trimble M: The intentional brain: a short history of neuropsychiatry. CNS Spectr 2016; 21:223–229
2.
Arambepola NM, Rickards H, Cavanna AE: The evolving discipline and services of neuropsychiatry in the United Kingdom. Acta Neuropsychiatr 2012; 24:191–198
3.
Ferro MA, Avery L, Fayed N, et al: QUALITÉ group: Child- and parent-reported quality of life trajectories in children with epilepsy: a prospective cohort study. Epilepsia 2017; 58:1277–1286
4.
Asato MR, Doss JL, Plioplys S: Clinic-friendly screening for cognitive and mental health problems in school-aged youth with epilepsy. Epilepsy Behav 2015; 48:97–102
5.
Dunn DW, Besag F, Caplan R, et al: Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Anxiety, depression and childhood epilepsy. Epileptic Disord (Epub ahead of print, May 19, 2016)
6.
Hamiwka L, Jones JE, Salpekar J, et al: Child psychiatry. Epilepsy Behav 2011; 22:38–46
7.
Salpekar J: Psychiatric comorbidities of childhood epilepsy, in Pellock’s Pediatric Epilepsy: Diagnosis and Therapy, 4th ed. Edited by Pellock JM, Nordli D, Sankar R, et al. New York, Demos Medical Publishing, 2017, pp 1163–1177
8.
Reynolds CR, Kamphaus RW: BASC-2: Behavioral Assessment System for Children Manual, 2nd ed. Circle Pines, Minn, AGS, 2004
9.
Gioia GA, Isquith PK, Guy SC, et al: Behavior Rating Inventory of Executive Function. Odessa, Fla, Psychological Assessment Resources, 2000
10.
Cramer JA, Westbrook LE, Devinsky O, et al: Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48. Epilepsia 1999; 40:1114–1121
11.
Salpekar JA, Mishra G, Hauptman AJ: Key issues in addressing the comorbidity of depression and pediatric epilepsy. Epilepsy Behav 2015; 46:12–18
12.
Salpekar JA, Mishra G: Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy. Epilepsy Behav 2014; 37:310–315

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 180 - 182
PubMed: 29558862

History

Received: 12 December 2017
Revision received: 11 February 2018
Accepted: 11 February 2018
Published online: 21 March 2018
Published in print: Summer 2018

Keywords

  1. pediatrics
  2. epilepsy
  3. services
  4. Diagnosis and Classification in Neuropsychiatry

Authors

Affiliations

Jay Salpekar, M.D., FANPA, FAES [email protected]
From the Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore.

Notes

Send correspondence to Dr. Salpekar; e-mail: [email protected]

Funding Information

The author reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share